On November 3, 2025, Datavault AI Inc. entered a License Agreement with Scilex Holding Company, granting a $10 million non-refundable license fee plus potential royalties totaling up to $2.55 billion; the agreement targets sectors like biotechnology and data through exclusive rights on proprietary materials.